Abstract:Using published studies, pharmacophore groups of anti‐inflammatory agents with 1,3,4‐oxadiazole and 1,2,4‐triazole nuclei were determined. Docking studies of identified pharmacophore groups on inducible nitric oxide synthase (iNOS) were performed to identify potent derivatives. New 1,3,4‐oxadiazoles (3a–f, 4a–f) and their cyclized 1,2,4‐triazolo[3,4‐b][1,3,4]thiadiazine derivatives (5a–e, 6a–e) were designed and synthesized as anti‐inflammatory agents targeting iNOS, prostaglandin E2 (PGE2), and interleukin‐6 (IL‐6). Due to the serious gastrointestinal side effects associated with prolonged use of current anti‐inflammatory therapies, various strategies such as the regulation of nitric oxide (NO) and prostaglandin E2 (PGE2) production have been explored in the field of anti‐inflammatory drug development. In this study, a series of disubstituted 1,3,4‐oxadiazoles (3a–f and 4a–f) and their cyclized 1,2,4‐triazole derivatives (5a–e and 6a–e) were synthesized and tested for their NO, PGE2, and interleukin‐6 (IL‐6) releasing inhibition ability. All of the compounds were observed to reduce lipopolysaccharide (LPS)‐induced nitrite production in a concentration‐dependent manner. Moreover, compounds 3b (50 μM) and 6d (1 μM) exhibited 63% and 49% inhibition, respectively, while indomethacin showed 52% at 100 μM. Based on a preliminary NO inhibition assay, 10 of the compounds (3a, 3b, 3e, 4b, 4d, 6a–e) were selected to be evaluated for in vitro PGE2, IL‐6, and inducible nitric oxide synthase (iNOS) inhibition. Notably, compound 6d proved to be the most active of the series with the lowest dose (1 μM), in comparison to the other further tested compounds (5–100 μM) and the reference drug indomethacin (100 μM). The inhibitory activity of the compounds was supported by docking simulations into the binding site of the iNOS protein receptor (Protein Data Bank [PDB]ID: 3E7G). The data showing that 4d reduced iNOS levels the most can be explained by the H‐bond with Tyr347 through oxadiazole and π–halogen interactions through the p‐bromo, in addition to aromatic interactions with protoporphyrin IX.

Oxadiazole Derivatives Containing 1,4-Benzodioxan As Potential Immunosuppressive Agents Against RAW264.7 Cells.

Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents

Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.

Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.

(E)-1,3-diphenyl-1h-pyrazole Derivatives Containing O-benzyl Oxime Moiety As Potential Immunosuppressive Agents: Design, Synthesis, Molecular Docking and Biological Evaluation.

Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives

Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells

Design, Synthesis, and Biological Evaluation of Chalcone Oxime Derivatives As Potential Immunosuppressive Agents

Design, Synthesis, and Evaluation of the COX-2 Inhibitory Activities of New 1, 3-dihydro-2H-indolin-2-one Derivatives

Design, Synthesis, and Biological Evaluation of 1,3,4-Oxadiazole Derivatives

Synthesis, Crystal Structure and Immunosuppressive Activity of Acylamide Derivatives Containing 1,4-Benzodioxan.

iNOS/PGE2 inhibitors as a novel template for analgesic/anti‐inflammatory activity: Design, synthesis, in vitro biological activity and docking studies

Novel 1,3,4-oxadiazole-2- thiol derivatives: Unlocking the therapeutic potential as anti-inflammatory and anticancer agents

Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors

Inhibitory Effect of Resveratrol Dimerized Derivatives on Nitric Oxide Production in Lipopolysaccharide-Induced Raw 264.7 Cells

Synthesis and evaluation of a novel series of quinoline derivatives with immunosuppressive activity.

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold

Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents

Design, Synthesis, and Anti-Inflammatory Activities of 12-Dehydropyxinol Derivatives

In Silico Study of Novel Oxadiazole Derivatives in Search of Potential Lead Compounds

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents